Marisa Wexler, MS,  senior science writer—

Exposure to low oxygen may help to ease the symptoms of Parkinson’s disease — but a lot more research is needed to conclusively determine the safety and effectiveness of this strategy for use among people with the neurodegenerative disorder, according to a new report. “From a clinical perspective, hypoxia…

The Parkinson KinetiGraph (PKG), a wrist-worn device resembling a watch, offers a moderate level of measurement for tracking symptom fluctuations and medication side effects in individuals with Parkinson’s disease. That’s according to the study “Application of single wrist-wearable accelerometry for objective motor diary assessment in…

Treatment with cianidanol, a plant molecule that can activate a specific estrogen receptor in the brain, showed neuroprotective potential in cell and animal models of Parkinson’s disease, a study reports. “The identification of cianidanol as a selective estrogen receptor beta agonist and evaluation of its neuroprotective…

A new set of guidelines, developed by a team of scientists in China, outline ways healthcare professionals can help people with Parkinson’s disease to deal with constipation — and the focus is on  emotional support to help patients, and emphasizing the importance of open dialogue. The study, “Breaking…

The use of over-the-counter pain medicines like ibuprofen and aspirin do not appear to influence the clinical progression of Parkinson’s disease, a recent study reveals. The study, “Non-steroidal anti-inflammatory drug use and markers of Parkinson’s disease progression: A retrospective cohort study,” was published in the Journal…

An informational podcast aims to instruct nursing students in Parkinson’s disease, helping them to feel more empathy for patients and equipping them with the knowledge needed for better Parkinson’s-specific care, a study reports. “By raising awareness of the disease, student nurses will develop an increased understanding, enabling them to…

Supernus Pharmaceuticals has asked the U.S. Food and Drug Administration (FDA) again to approve the apomorphine infusion pump SPN-830 for treating Parkinson’s disease. “We look forward to continuing our effort with the FDA throughout the NDA [new drug application] review process to bring a promising alternative to…

Toxic clumps of the protein alpha-synuclein change the way the brain cells most affected by Parkinson’s disease utilize energy, a study shows. Its researchers wanted a clearer understanding of how “key metabolic processes” are affected by the protein’s aggregation, damaging “vulnerable” nerve cells within the brain, they wrote. To…

Mark Denham, PhD, a scientist in Denmark, has been awarded a patent that covers a new way of using stem cells to create cell therapies for Parkinson’s disease. Securing the patent, which provides two decades of intellectual property protection for the technology, is a first step toward establishing a…

Dosing has begun in a Phase 1 clinical trial that is testing GT-02287, an experimental oral medication being developed to treat Parkinson’s disease caused by mutations in the GBA1 gene. The first two participants in the trial have been dosed, according to the therapy’s developer, Gain Therapeutics. “Initiating first-in-human…